Silo Pharma
SILO
4 hedge funds and large institutions have $273K invested in Silo Pharma in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.17% more ownership
Funds ownership: 0% → 0.17% (+0.17%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
+$138K |
| 2 |
SC
Shay Capital
New York
|
+$87.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$34.9K |
| 4 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$462 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FIA
1
FNY Investment Advisers
New York
| $144K | +$138K | +1,791 | New |
|
|
SC
2
Shay Capital
New York
| $92K | +$87.3K | +1,134 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $37K | +$34.9K | +453 | New |
|
|
WIM
4
Westside Investment Management
Santa Monica,
California
| – | +$462 | +6 | New |
|
SILO Hedge Fund Activity: Q3 2022 in Review
4 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q3 2022, worth a combined $273K.
Buyers outnumbered sellers: 4 funds opened new SILO positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was FNY Investment Advisers, opening a new position worth an estimated $138K.
- 4 institutional investors held Silo Pharma (SILO) as of Q3 2022, up from 0 in Q2 2022.
- Funds reported $273K of Silo Pharma stock for Q3 2022.
- 4 funds opened new Silo Pharma positions in Q3 2022 and 0 closed out, a net change of +4 holders.
- The largest Silo Pharma buyer in Q3 2022 was FNY Investment Advisers, an estimated $138K added.
Based on aggregated 13F filings for Q3 2022.